153 related articles for article (PubMed ID: 8558416)
1. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
Graham SH; Chen J; Lan JQ; Simon RP
J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
[TBL] [Abstract][Full Text] [Related]
2. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
3. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
Hu P; Diemer NH; Bruhn T; Johansen FF
J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
[TBL] [Abstract][Full Text] [Related]
4. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
[TBL] [Abstract][Full Text] [Related]
5. A study of the dose dependency of a glycine receptor antagonist in focal ischemia.
Chen J; Graham S; Moroni F; Simon R
J Pharmacol Exp Ther; 1993 Nov; 267(2):937-41. PubMed ID: 8246170
[TBL] [Abstract][Full Text] [Related]
6. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
Tortella FC; Britton P; Williams A; Lu XC; Newman AH
J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies.
Williams AJ; Dave JR; Phillips JB; Lin Y; McCabe RT; Tortella FC
J Pharmacol Exp Ther; 2000 Jul; 294(1):378-86. PubMed ID: 10871336
[TBL] [Abstract][Full Text] [Related]
11. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
12. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat.
Smith SE; Meldrum BS
Funct Neurol; 1993; 8(1):43-8. PubMed ID: 8330753
[TBL] [Abstract][Full Text] [Related]
13. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Lo EH; Pierce AR; Mandeville JB; Rosen BR
Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
[TBL] [Abstract][Full Text] [Related]
16. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
18. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
[TBL] [Abstract][Full Text] [Related]
19. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
20. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
